U.S. neurotechnology company Paradromics is launching a clinical trial to restore lost voices using human brain signals.
Neuroscientists are finding that when two people interact, their brains do not work in isolation. Instead, patterns of ...
Paradromics received regulatory approval to test its BCI device in a small clinical trial to assess its safety and efficacy.
US brain-computer-interface startup Paradromics is quickly establishing itself as a major player in the neural-device space, ...
The ability to analyze the brain's neural connectivity is emerging as a key foundation for brain-computer interface (BCI) ...
The ability of these devices to access aspects of a person’s innermost life, including preconscious thought, raises the ...
Neurotechnology company Paradromics will test its device in a trial aimed at safely restoring speech for people with severe motor impairments.
Instead, through the fund that bears their name, they have helped raise more than $550 million for The Miami Project to Cure ...